Literature DB >> 19522000

Clinical evaluation of the new Amplatzer duct occluder II for patent arterial duct occlusion.

V Bhole1, P Miller, C Mehta, O Stumper, Z Reinhardt, J V De Giovanni.   

Abstract

BACKGROUND: Several devices such as coils and Amplatzer duct occluder (ADO) are used for catheter closure of patent arterial ducts (PDA). These carry a high success rate but residual shunts, suboptimal device orientation, and technical problems are encountered. The Amplatzer duct occluder II (ADO II) is designed to address these limitations.
OBJECTIVES: To evaluate the technical features of the new ADO II device for PDA closure and document the immediate/early closure rate, complications and device behavior during implantation.
METHODS: Prospective, two center study from February 2008 to January 2009. Twenty-seven patients (18 females) received the ADO II. The median age was 22 months (range: 7 months-68 years) and the median weight was 11.7 kg (range: 6.9-108). The median PDA diameter was 2.6 mm (range: 1-4.4). The approach was arterial in 13 and venous in 14 patients. Follow-up included echocardiography at 1 day and 1 month postimplantation.
RESULTS: All implantations were technically successful with immediate complete angiographic closure in 21 and trivial contrast flow in six patients. The median procedure time was 43 min (range: 15-82) and the fluoroscopy time was 6 min (range: 2.2-26.5). Echocardiography confirmed no residual shunts on the following day. There were no complications.
CONCLUSION: The new ADO II is a versatile and very effective device for closure of PDAs of various shapes, lengths, and up to diameters of 5.5 mm. The disc articulations, high early closure rate, arterial or venous approach options, and small diameter delivery catheter are all beneficial features. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19522000     DOI: 10.1002/ccd.22095

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  4 in total

1.  Comparison of the efficacy of different-sized Amplatzer duct occluders (I, II, and II AS) in children weighing less than 10 kg.

Authors:  Osman Baspinar; Ahmet Irdem; Ercan Sivasli; Derya Aydin Sahin; Metin Kilinc
Journal:  Pediatr Cardiol       Date:  2012-05-31       Impact factor: 1.655

2.  Percutaneous closure of a moderate to large tubular or elongated patent ductus arteriosus in children younger than 3 years: is the ADO II appropriate?

Authors:  Saktheeswaran Mahesh Kumar; Venkateshwaran Subramanian; Sasidharan Bijulal; Kavassery Mahadevan Krishnamoorthy; Sivasubramonian Sivasankaran; Jaganmohan A Tharakan
Journal:  Pediatr Cardiol       Date:  2013-04-17       Impact factor: 1.655

3.  Ductal closure using the Amplatzer duct occluder type two: experience in Port Elizabeth hospital complex, South Africa: cardiovascular topic.

Authors:  Lungile Pepeta; Adele Dippenaar
Journal:  Cardiovasc J Afr       Date:  2013-07       Impact factor: 1.167

4.  Patent ductus arteriosus closure using Occlutech® Duct Occluder, experience in Port Elizabeth, South Africa.

Authors:  Lungile Pepeta; Adele Greyling; Mahlubandile Fintan Nxele; Zongezile Masonwabe Makrexeni
Journal:  Ann Pediatr Cardiol       Date:  2017 May-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.